Articles

Keep up to date with the latest developments on medical cannabis

Our actions

Keep up to date with the latest developments on medical cannabis

Our actions

Keep up to date with the latest developments on medical cannabis

Experimentation with cannabis for medical use

Appel d'offres vaporisateurs On 26 March, Health Minister Olivier Véran was in Clermont-Ferrand to announce the launch of the therapeutic cannabis experiment. Medical cannabis will be made available to patients for two years in two forms: oils administered orally and flowering tops (dried flowers) to be vaporised for inhalation. Following ...
Lire La Suite >
/ Press release

Experimentation with cannabis for medical use

Call for tenders sprayers On 26 March, Health Minister Olivier Véran was in Clermont-Ferrand to announce the launch of the therapeutic cannabis experiment. Medical cannabis will be made available to patients for two years in two forms: oils administered orally and flowering tops (dried flowers) to be vaporised for inhalation ...
Lire La Suite >
/ Press release
Résultats expérimentation ANSM

Medical Cannabis: After the selection of foreign manufacturers, the place is now open to French companies.

The Agence Nationale de Sécurité du Médicament (ANSM) has published the results of the call for tenders for the supply and distribution of cannabis-based drugs for experimentation. RESULTS OF THE CALL FOR PROJECTS DelleD had applied and was one of the few French companies to have responded to this call ...
Lire La Suite >
/ Press release
Système endocannabinoide

Cannabis and the endocannabinoid system: mode of action

Cannabinoids act on the body through the endocannabinoid system.  The phytocannabinoids in the cannabis plant work in a similar way to our naturally occurring endocannabinoids. The endocannabinoid system The human body has specific receptors on the surface of many cell types for cannabinoids. Our body also produces several endogenous cannabinoids ...
Lire La Suite >
/ Article

Therapeutic Cannabis to the rescue of heavy pathologies

A French pioneer in therapeutic cannabis-based medicines, LaFleur created by DelleD proposes the experimentation of a medical device of cannabis flower by vaporization in order to obtain a marketing authorization from the ANSM (National Agency for the Safety of Medicines and Health Products). DELLED PARTNERS WITH RYAH TO EXPERIMENT A ...
Lire La Suite >
/ Press release

DelleD raises 3 million euros for therapeutic cannabis in France

Thanks to the private investor financing signed on July 31, 2020, DelleD can now accelerate its LaFleur project and develop its new oncology treatment based on cannabis assets. DELLED IS PURSUING ITS FLOWER RESEARCH PROGRAM AND SETTING UP IN ANGERS, FRANCE. Large-scale, long-term financing provides DelleD with the opportunity to ...
Lire La Suite >
/ Press release

The first stocks of therapeutic cannabis delivered in France to develop a drug

In collaboration with DelleD SAS ("DelleD" or the "Company"), a French public laboratory received the first stocks of cannabis a few days ago. They will be used to carry out work on the processing for the elaboration of the first batches of cannabis intended for medical use and produced on ...
Lire La Suite >
/ Press release

Experimentation with cannabis for medical use

Appel d'offres vaporisateurs On 26 March, Health Minister Olivier Véran was in Clermont-Ferrand to announce the launch of the therapeutic cannabis experiment. Medical cannabis will be made available to patients for two years in two forms: oils administered orally and flowering tops (dried flowers) to be vaporised for inhalation. Following ...
Lire La Suite >
/ Press release

Experimentation with cannabis for medical use

Call for tenders sprayers On 26 March, Health Minister Olivier Véran was in Clermont-Ferrand to announce the launch of the therapeutic cannabis experiment. Medical cannabis will be made available to patients for two years in two forms: oils administered orally and flowering tops (dried flowers) to be vaporised for inhalation ...
Lire La Suite >
/ Press release
Résultats expérimentation ANSM

Medical Cannabis: After the selection of foreign manufacturers, the place is now open to French companies.

The Agence Nationale de Sécurité du Médicament (ANSM) has published the results of the call for tenders for the supply and distribution of cannabis-based drugs for experimentation. RESULTS OF THE CALL FOR PROJECTS DelleD had applied and was one of the few French companies to have responded to this call ...
Lire La Suite >
/ Press release
Système endocannabinoide

Cannabis and the endocannabinoid system: mode of action

Cannabinoids act on the body through the endocannabinoid system.  The phytocannabinoids in the cannabis plant work in a similar way to our naturally occurring endocannabinoids. The endocannabinoid system The human body has specific receptors on the surface of many cell types for cannabinoids. Our body also produces several endogenous cannabinoids ...
Lire La Suite >
/ Article

Therapeutic Cannabis to the rescue of heavy pathologies

A French pioneer in therapeutic cannabis-based medicines, LaFleur created by DelleD proposes the experimentation of a medical device of cannabis flower by vaporization in order to obtain a marketing authorization from the ANSM (National Agency for the Safety of Medicines and Health Products). DELLED PARTNERS WITH RYAH TO EXPERIMENT A ...
Lire La Suite >
/ Press release

DelleD raises 3 million euros for therapeutic cannabis in France

Thanks to the private investor financing signed on July 31, 2020, DelleD can now accelerate its LaFleur project and develop its new oncology treatment based on cannabis assets. DELLED IS PURSUING ITS FLOWER RESEARCH PROGRAM AND SETTING UP IN ANGERS, FRANCE. Large-scale, long-term financing provides DelleD with the opportunity to ...
Lire La Suite >
/ Press release

The first stocks of therapeutic cannabis delivered in France to develop a drug

In collaboration with DelleD SAS ("DelleD" or the "Company"), a French public laboratory received the first stocks of cannabis a few days ago. They will be used to carry out work on the processing for the elaboration of the first batches of cannabis intended for medical use and produced on ...
Lire La Suite >
/ Press release
error: Contenu protégé!

Nous souhaitons que les professionnels de santé qui souhaitent se renseigner sur le cannabis médical aient accès aux dernières recherches scientifiques pour aider les patients en impasse thérapeutique.

L’espace membre est exclusivement réservé aux pro de santé, nous vérifions les informations transmises.
Si votre candidature est acceptée vous recevrez un mail de confirmation avec vos codes d’accès